Assertio Holdings Dividend

Dividend criteria checks 0/6

Assertio Holdings does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	2.3%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-US$3.50
Dividend yield forecast in 3Y	n/a

Recent dividend updates

No updates

Recent updates

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 07

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Apr 18

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Mar 13

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Apr 26

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Mar 02

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ASRT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ASRT's dividend payments have been increasing.

Dividend Yield vs Market

Assertio Holdings Dividend Yield vs Market

How does ASRT dividend yield compare to the market?
Segment	Dividend Yield
Company (ASRT)	n/a
Market Bottom 25% (US)	1.5%
Market Top 25% (US)	4.6%
Industry Average (Pharmaceuticals)	2.3%
Analyst forecast in 3 Years (ASRT)	n/a

Notable Dividend: Unable to evaluate ASRT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ASRT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ASRT's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ASRT has not reported any payouts.

Assertio Holdings Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Assertio Holdings, Inc. to Report Q1, 2024 Results on May 06, 2024

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 27%

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Full year 2023 earnings: EPS misses analyst expectations

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Assertio Holdings, Inc. to Report Q4, 2023 Results on Mar 11, 2024

New major risk - Share price stability

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against Assertio Holdings, Inc

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

New minor risk - Market cap size

Assertio Holdings, Inc. Announces CFO Changes

New minor risk - Profitability

Consensus EPS estimates fall by 18%

Assertio Holdings, Inc. to Report Q3, 2023 Results on Nov 08, 2023

President recently sold US$479k worth of stock

President notifies of intention to sell stock

New major risk - Shareholder dilution

Independent Director notifies of intention to sell stock

New minor risk - Share price stability

Assertio Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $25 million.

Consensus revenue estimates increase by 13%, EPS downgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023

Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).

Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors

Assertio Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Independent Director recently sold US$652k worth of stock

President exercised options and sold US$2.9m worth of stock

Consensus EPS estimates fall by 30%, revenue upgraded

Assertio Holdings, Inc. Raises Earnings Guidance for the Full Year of 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 17%

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued

Price target increased by 9.6% to US$7.88

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Investor sentiment improves as stock rises 18%

Consensus EPS estimates increase by 164%

President exercised options and sold US$257k worth of stock

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 11%

Investor sentiment deteriorated over the past week

Insufficient new directors

Assertio Holdings, Inc. Revises Net Product Sales Guidance for the Year 2022

Assertio Holdings, Inc. Revises Earnings Guidance for the Full Year 2022

Assertio Holdings, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Assertio Holdings Looks Good To Rebound After Recent Price Plunge

Assertio Holdings: Substantial Upside

Assertio Holdings, Inc. Raises Earnings Guidance for the Year 2022

Assertio Therapeutics Q2 2022 Earnings Preview

Assertio Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Assertio Holdings: Management Still Swimming Against The Tide

Assertio's Phenomenal Turnaround

Assertio Holdings, Inc. Re-Affirms Sales Guidance for the Full Year of 2022

Levi & Korsinsky, LLP Announces Propose Settlement Against Assertio Therapeutics, Inc. Securities Litigation

Assertio Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Assertio Holdings: Recent Breakout To Lead To Sustained Gains

Assertio Holdings, Inc., Annual General Meeting, May 04, 2022

Assertio Holdings, Inc. to Report Fiscal Year 2021 Results on Mar 09, 2022

Assertio's Digital Strategy Looks To Be Paying Off

Assertio Holdings Inc Regains Compliance with Nasdaq Minimum Bid Price Requirement

Assertio Holdings, Inc. Provides Earnings Guidance for the Full Year 2021

Assertio shares rise on Q1 revenue strength, provides FY forecast

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. to Report Q4, 2020 Results on Mar 11, 2021

Assertio Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $14.012 million.